To answer Dr.SleepRoch's question specifically:

From a clinical standpoint, Semaglutide cardiovascular is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.

Can confirm — my data shows the same pattern.

OP here — wow, did not expect this much response! Thank you all for the thoughtful replies on Semaglutide.

To answer MaxMetOK: my doctor and I discussed the options and went with brand.

Quick update: I have noticed more improvement since posting this. Thanks again for the evidence-based discussion — this is exactly why I posted in a science-based community. 🙏

Subscribing to this thread. Semaglutide is exactly what I've been researching. 🙏

+1 to Dr.AddMedPHL. Especially the point about "3%, triglycerides 207 → 107 mg/dL, hsCRP..." — I have seen the same in my own experience with Semaglutide.